Stock listing
Formosa Laboratories, Inc.
Selected listing: 4746 · TWSE · TWD · TW
Formosa Laboratories, Inc. (TWSE:4746), Health Technology. Latest release Apr 30, 2026: Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI)…
- Ticker
- TWSE:4746
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TWSE
- Currency
- TWD
About Formosa Laboratories, Inc.
Formosa Laboratories, Inc. is a publicly traded company on the Taiwan market under the ticker 4746. Formosa Laboratories focuses on providing high-quality products and services to meet the needs of its clients.
Latest news from Formosa Laboratories, Inc.
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
April 30, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
February 23, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
January 12, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
December 3, 2025
Formosa Plastics Corporation, U.S.A. Unveils the Largest Horizontal Polypropylene Reactor in North America
September 23, 2025
Research Formosa Laboratories, Inc.
Formosa Laboratories, Inc. company profile
View the public company page for Formosa Laboratories, Inc. on 6ix.
Formosa Laboratories, Inc. news
Read company news and market updates connected to Formosa Laboratories, Inc..
Formosa Laboratories, Inc. investor events
Find investor webinars, events, and replay context for Formosa Laboratories, Inc..